Biomarker and digital technologies for the proactive care of autoimmune diseases.
Diagnostics β’ Digital Health β’ Digital Therapeutics β’ Lupus β’ Multiple Sclerosis
11 - 50
π° $5M Series A on 2020-01
November 10
11 - 50
Oversee operations at a biotech firm focusing on autoimmune conditions.
πΊπΈ United States β Remote
π° $5M Series A on 2020-01
β° Full Time
π΄ Lead
βοΈ Operations